| John Christopher Mcauliffe, MD, PHD | |
|
1521 Jarret Pl, Bronx, NY 10461-2606 | |
| (718) 862-8840 | |
| Not Available |
| Full Name | John Christopher Mcauliffe |
|---|---|
| Gender | Male |
| Speciality | Surgical Oncology |
| Experience | 15 Years |
| Location | 1521 Jarret Pl, Bronx, New York |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205060068 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086X0206X | Surgery - Surgical Oncology | 273263 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montefiore Medical Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montefiore Medical Center | 3779496021 | 2003 |
News Archive
Research conducted at University of Nevada, Reno and licensed through the University's Technology Transfer Office is featured in the technology transfer publication "Better World Report" for a remarkable second year in a row.
Results of a new study led by the University of Maryland School of Public Health show that people infected with the virus that causes COVID-19 exhale infectious virus in their breath – and those infected with the Alpha variant (the dominant strain circulating at the time this study was conducted) put 43 to 100 times more virus into the air than people infected with the original strains of the virus.
People with "prediabetes" (a high risk state for overt type 2 diabetes) who experience a period of normal glucose regulation are 56% less likely to develop diabetes 5∙7 years later, according to a new research Article presented at the American Diabetes Association 72nd Scientific Sessions on Saturday 9 June, and published Online First in The Lancet. This is one of four Articles (all presented at the American Diabetes Association 72nd Scientific Sessions) and a Series of three papers that are part of a special Lancet theme issue on diabetes [1].
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
Researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California Berkeley have demonstrated that diamonds may hold the key to the future for nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) technologies.
› Verified 1 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
Research conducted at University of Nevada, Reno and licensed through the University's Technology Transfer Office is featured in the technology transfer publication "Better World Report" for a remarkable second year in a row.
Results of a new study led by the University of Maryland School of Public Health show that people infected with the virus that causes COVID-19 exhale infectious virus in their breath – and those infected with the Alpha variant (the dominant strain circulating at the time this study was conducted) put 43 to 100 times more virus into the air than people infected with the original strains of the virus.
People with "prediabetes" (a high risk state for overt type 2 diabetes) who experience a period of normal glucose regulation are 56% less likely to develop diabetes 5∙7 years later, according to a new research Article presented at the American Diabetes Association 72nd Scientific Sessions on Saturday 9 June, and published Online First in The Lancet. This is one of four Articles (all presented at the American Diabetes Association 72nd Scientific Sessions) and a Series of three papers that are part of a special Lancet theme issue on diabetes [1].
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
Researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California Berkeley have demonstrated that diamonds may hold the key to the future for nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) technologies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Christopher Mcauliffe, MD, PHD 1521 Jarret Pl, Bronx, NY 10461-2606 Ph: (718) 862-8840 | John Christopher Mcauliffe, MD, PHD 1521 Jarret Pl, Bronx, NY 10461-2606 Ph: (718) 862-8840 |
News Archive
Research conducted at University of Nevada, Reno and licensed through the University's Technology Transfer Office is featured in the technology transfer publication "Better World Report" for a remarkable second year in a row.
Results of a new study led by the University of Maryland School of Public Health show that people infected with the virus that causes COVID-19 exhale infectious virus in their breath – and those infected with the Alpha variant (the dominant strain circulating at the time this study was conducted) put 43 to 100 times more virus into the air than people infected with the original strains of the virus.
People with "prediabetes" (a high risk state for overt type 2 diabetes) who experience a period of normal glucose regulation are 56% less likely to develop diabetes 5∙7 years later, according to a new research Article presented at the American Diabetes Association 72nd Scientific Sessions on Saturday 9 June, and published Online First in The Lancet. This is one of four Articles (all presented at the American Diabetes Association 72nd Scientific Sessions) and a Series of three papers that are part of a special Lancet theme issue on diabetes [1].
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
Researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California Berkeley have demonstrated that diamonds may hold the key to the future for nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) technologies.
› Verified 1 days ago
Dr. Sydney George Mccalla, M.B.B.S Surgery Medicare: Accepting Medicare Assignments Practice Location: 234 E 149th St, Bronx, NY 10451 Phone: 718-579-5000 Fax: 718-579-4620 | |
Cosman Camilo Mandujano Bejarano, Surgery Medicare: Medicare Enrolled Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 832-675-0676 | |
Dr. Mahalingam Sivakumar, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1650 Selwyn Ave, Acn Morris, Bronx, NY 10457 Phone: 718-960-1320 Fax: 718-960-1051 | |
Dr. Rajendra J Saraiya, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: Department Of Surgery 1650, Selwyn Avenue, Apt # 4a, Bronx, NY 10457 Phone: 718-960-1210 | |
Dr. Jeannine K Giacovelli, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 158r Hawkins St., Bronx, NY 10464 Phone: 917-968-0088 | |
Dr. Eugene Michael Edynak, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Howard R Doyle, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: Mmc - Critical Care Medicine Moses Div, 111 East 210th Street, Bronx, NY 10467 Phone: 718-920-2479 |